These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22936064)

  • 1. TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation.
    Patel KP; Khokhar FA; Muzzafar T; James You M; Bueso-Ramos CE; Ravandi F; Pierce S; Medeiros LJ
    Mod Pathol; 2013 Feb; 26(2):195-203. PubMed ID: 22936064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype.
    Saburi M; Ogata M; Satou T; Soga Y; Itani K; Kohno K; Kondo Y; Nakayama T
    Int J Hematol; 2020 Jul; 112(1):17-23. PubMed ID: 32253665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes.
    Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S
    Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
    Drexler HG; Sperling C; Ludwig WD
    Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia.
    Foa R; Casorati G; Giubellino MC; Basso G; Schirò R; Pizzolo G; Lauria F; Lefranc MP; Rabbitts TH; Migone N
    J Exp Med; 1987 Mar; 165(3):879-90. PubMed ID: 3102679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia.
    De Bellis E; Ottone T; Mercante L; Falconi G; Cugini E; Consalvo MI; Travaglini S; Paterno G; Piciocchi A; Rossi ELL; Gurnari C; Maurillo L; Buccisano F; Arcese W; Voso MT
    Leuk Res; 2020 Dec; 99():106462. PubMed ID: 33091616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
    Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
    Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
    Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
    Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/or T cell receptor gene rearrangement.
    Willière G; Stockinger H; Köller U; Majdic O; Schnabl E; Lutz D; Bettelheim P; Knapp W
    Leukemia; 1990 Apr; 4(4):278-81. PubMed ID: 1694941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular roulette: nucleophosmin mutations in AML are orchestrated through N-nucleotide addition by TdT.
    Borrow J; Dyer SA; Akiki S; Griffiths MJ
    Blood; 2019 Dec; 134(25):2291-2303. PubMed ID: 31650162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).
    Stasi R; Del Poeta G; Venditti A; Masi M; Stipa E; Dentamaro T; Cox C; Dallapiccola B; Papa G
    Blood; 1994 Mar; 83(6):1619-25. PubMed ID: 8123853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
    Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
    Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.
    Schachner J; Kantarjian H; Dalton W; McCredie K; Keating M; Freireich EJ
    Leukemia; 1988 Oct; 2(10):667-71. PubMed ID: 3172842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia.
    Parreira A; Pombo de Oliveira MS; Matutes E; Foroni L; Morilla R; Catovsky D
    Br J Haematol; 1988 Jun; 69(2):219-24. PubMed ID: 3164631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal deoxynucleotidyl transferase in acute myeloid leukaemia.
    Jani P; Verbi W; Greaves MF; Bevan D; Bollum F
    Leuk Res; 1983; 7(1):17-29. PubMed ID: 6572772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosis.
    Amadori S; Venditti A; Del Poeta G; Stasi R; Buccisano F; Bruno A; Tamburini A; Cox MC; Maffei L; Aronica G; Simone MD; Adorno G; Masi M; Tribalto M; Papa G
    Ann Hematol; 1996 Apr; 72(4):208-15. PubMed ID: 8624374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping.
    Oster W; König K; Ludwig WD; Ganser A; Lindemann A; Mertelsmann R; Herrmann F
    Leuk Res; 1988; 12(11-12):887-95. PubMed ID: 2851073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal deoxynucleotidyl transferase promotes acute myeloid leukemia by priming FLT3-ITD replication slippage.
    Borrow J; Dyer SA; Akiki S; Griffiths MJ
    Blood; 2019 Dec; 134(25):2281-2290. PubMed ID: 31650168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.